667sek
9,2 %
Date:2025-06-27Time:11:59:18Latest report:Q1-2025List:First NorthTicker:ONCOZ
Market Cap:80 msekEnterprise Value:78 msekNet Sales:2,71 msekEarnings:-6,27 msekEmployees:0ISIN:SE0015504097

Ratios

10-year key figure history for OncoZenge turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for OncoZenge with index and moving average MA50 and MA200.

Stockprice:6,67
MA50:5,20
MA200:5,91
Price/MA200:14,9 %
RSI (14):63,8
Price/MA50:30,6 %

Description

OncoZenge is a Swedish pharmaceutical company that develops treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. After completing phase 2 studies, the company's product candidate is under further development as a basis for applying for regulatory market approvals and commercialization. OncoZenge is headquartered in Bromma.

Pharmaceuticals